| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| RYAN THOMAS L | CEO & Chairman, Director | 1929 ALLEN PARKWAY, HOUSTON | Jessica Vu, Attorney-in-Fact for Thomas L. Ryan | 12 Aug 2025 | 0001243194 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SCI | Common Stock | Options Exercise | $5,622,857 | +149,823 | +15% | $37.53 | 1,132,156 | 08 Aug 2025 | Direct | |
| transaction | SCI | Common Stock | Sale | $12,058,774 | -149,823 | -13% | $80.49 | 982,333 | 08 Aug 2025 | Direct | F1 |
| transaction | SCI | Common Stock | Options Exercise | $6,643 | +177 | +0.02% | $37.53 | 982,510 | 08 Aug 2025 | Direct | |
| transaction | SCI | Common Stock | Sale | $14,308 | -177 | -0.02% | $80.84 | 982,333 | 08 Aug 2025 | Direct | F2 |
| holding | SCI | Common Stock | 157,899 | 08 Aug 2025 | By Three Children's Trusts | F3 | |||||
| holding | SCI | Common Stock | 519,105 | 08 Aug 2025 | By Deferred Compensation Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SCI | Employee stock option (right to buy) | Options Exercise | $0 | -149,823 | -100% | $0.000000 | 177 | 08 Aug 2025 | Common Stock | 149,823 | $37.53 | Direct | F4 |
| transaction | SCI | Employee stock option (right to buy) | Options Exercise | $0 | -177 | -100% | $0.000000 | 0 | 08 Aug 2025 | Common Stock | 177 | $37.53 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The shares were sold in multiple transactions at prices ranging from $79.8000 to $80.7800 per share on August 8, 2025. The $80.4868 sale price reported above is the weighted average sale price. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F2 | The shares were sold in multiple transactions at prices ranging from $80.8100 to $80.8700 per share on August 8, 2025. The $80.8359 sale price reported above is the weighted average sale price. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | The shares are held by a trust over which the reporting person has investment control but is not the trustee. |
| F4 | The option vested in three equal annual installments on February 13, 2019, 2020, and 2021. |